Sleep difficulty mediates effects of vasomotor symptoms on mood in younger breast cancer survivors

Vincent, Amanda; Ranasinha, Sanjeeva; Sayakhot, Padaphet; Mansfield, Darren; Teede, Helena

doi:10.3109/13697137.2014.900745

Cited by 23 publications

(20 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In contrast, women with ovarian cancer who were premenopausal before surgical oophorectomy had worse sleep trajectories over time than women who were postmenopausal; this effect may have been due to immediate menopause leading to the onset of menopausal symptoms that disturb sleep quality (Clevenger et al, 2013). Indeed, sleep disturbance has been significantly related to endocrine symptoms, including vasomotor symptoms (hot flashes and night sweats), sexual dysfunction and weight gain (Sanford et al, 2013;Vincent, Ranasinha, Sayakhot, Mansfield, & Teede, 2014) and fatigue (Berger, Gerber, & Mayer, 2012). However, few studies have explored the prevalence of menopausal symptoms and their relationships with sleep and fatigue among women with endometrial cancer.…”

Section: Introductionmentioning

confidence: 99%

Associations among menopausal symptoms, sleep and fatigue in Taiwanese women with endometrial cancer

Tsai

Chang

et al. 2016

Eur J Cancer Care

View full text Add to dashboard Cite

The purpose of this study was to explore the relationships among menopausal symptoms, sleep quality and fatigue in women with endometrial cancer. Participants were 95 women (mean age = 57.44 ± 10.15 years) diagnosed with endometrial cancer and who had completed their treatment before data collection. Each woman completed three structured questionnaires: the Functional Assessment of Cancer Therapy-Endocrine Symptoms (endocrine symptom subscale), the Pittsburgh Sleep Quality Index and the Functional Assessment of Chronic Illness Therapy-Fatigue. Participants' worst menopausal symptom was sexual pain. In addition, menopausal symptoms were worse in women with surgical menopause than with natural menopause. The majority of women had poor sleep quality (55%), and women with fatigue reported worse sleep quality and menopausal symptoms than those without fatigue. However, higher fatigue was significantly related to shorter time since diagnosis. Together, three variables (time since diagnosis, menopausal symptoms and sleep quality) explained 39% of the variance in fatigue, with menopausal symptoms being the strongest predictor. Healthcare providers can assess menopausal symptoms and sleep quality during and after treatment of women with endometrial cancer. Such assessments would allow timely interventions to alleviate fatigue and menopausal symptoms in this population, thus improving their quality of life.

show abstract

Section: Introductionmentioning

confidence: 99%

Associations among menopausal symptoms, sleep and fatigue in Taiwanese women with endometrial cancer

Tsai

Chang

et al. 2016

Eur J Cancer Care

View full text Add to dashboard Cite

show abstract

“…По GCS и HADS при обследовании 908 женщин [37] обнаружены корреляции между психоýмоциональными (тревога, депрессия, напряжение, утомляемость, слезливость, сексуальная дисфункция), мочеполовыми (дизурия, никтурия, недержание) и вагинальными (вагинальная боль, диспареуния, жжение, сухость, кровотечение postcoital) нарушениями. С помощью ýтих же валидизированных опросников при неметастатическом раке молочной железы [38] вызванная хирургической операцией, химио-и лучевой терапией менопауза диагностирована у 80% женщин, сопровождавшаяся клинической и субклинической тревогой и депрессией (p = 0,015). Women's Health Questionnaire -валидизированный и надежный инструмент оценки психического состояния женщин с КД.…”

Section: оценка психометрических свойств опросников при проявлениях кдunclassified

Depressive disorders in women of climacteric age (review of foreign literature for 2012–2016)

Бохан¹,

Лукьянова²,

Симуткин³

2018

Bûll. sib. med.

View full text Add to dashboard Cite

Objective:to systematically review foreign literature and interpret results of the review. Tasks: to review foreign papers where factors are considered which provoke development of depression: hormonal, psychological, social as well as neuromediators, hormonal and immune disturbances in depressive disorders in women with physiological climacteric and climacteric syndrome; issues of differential diagnostics of depressions, psychopharmaco- and psychotherapy with subsequent evaluation of clinical efficiency; personality profile of pateints with affective psychopathology.Methods of search: by keywords in Web of Science Core Collection database across foreign journals (2012– 2016). Criteria of inclusion of papers in the review are determined by themes of studies: 1) women of climacteric age; 2) presence of depression or depressive symptoms; 3) presence of climacteric disturbances. In the abstract-bibliographic and scientometric database Web of Science Core Collection 70 bibliographic sources are selected across foreign journals between 2012 and 2016, including journals with high Impact Factor. Studies included in the review are performed at the university clinics, specialized centers. Clinical and sociodemographic characteristics of female patients meet the criterion of compatibility. Most discussed papers are devoted to study of clinical and social-psychological factors of development of climacteric depression. In a number of papers the efficiency of antidepressant therapy, alternative methods and supplementary therapy in women with depressive disorders, climacteric disturbances and co-occurring physical diseases is shown. Most works are performed with involvement of questionnaires (sociodemographic data, anamnesis) and international clinical scales. The main results of the discussed papers are outlined in thematic rubrics.Conclusion. The European and American papers are used in this review more frequently; studies from Asian countries are used more seldom. Reviewed foreign publications reflect worldwide trend to increase of climacteric depression (CD) in the female population with presence in the anamnesis of adolescent (psychoendocrine alteration) and postpartum depression, premenstrual syndrome. Low timely diagnostics of depressions, high incidence rate of somaticized CD are noted. In the structure of climacteric syndrome the psychoemotional disturbances predominate above neurovegetative and metabolic-endocrine or are combined with vegetative dysfunction. The participation in formation of CD (with predominance of mild/moderate severity) of neurohormonal, genetic, biochemical, social-environmental, psychological factors is shown. In the reviewed sources low mood, loss of previous priorities, decrease of productivity and concentration of attention, position of being unprotected, dependence, lack of confidence, self-humiliation, repentance, unbelief in future, insomnias, hypo-/hyperrexia with change of body mass are described in CD but there are no publications on suicidal ideation. It is indicated that CD can flow with hysteric- and nosophobic, somatohypochondriac and asthenohypochondriac component. The authors consider that somatization as an experience of climacteric stress leads to somaticized CD with accent on physical symptoms and repression of depression and anxiety although an association of specific somatic nosologies with symptoms of CD is not described. The association of CD with social-environmental factors (gender, education, profession, social position, financial wealth) is discussed, achievement of the woman is considered as a actor of reduction of CD risk. The authors are highly interested in search for genetic markers (heredity, suicides in relatives), impairment of neuromediator exchange (neurotransmitters serotonin, dopamine, adrenaline, and noradrenaline), neuromorphologic alterations in brain sensorimotor cortex (motor function, attention, perception, memory, and emotional-motivational response), hormonal disturbances (neuroendocrine and metabolic) and psychoneuroimmunological patterns of association with CD. Psychopharmacotherapy in CD is constructed with account for depressive symptoms (antidepressants of activating/sedative action in long-term maintenance regime), background and co-occurring diseases (adequate and pathogenetic and immunotherapy) with involvement in case of absence of contraindications of substitutive hormonotherapy (estrogen, progesterone). Beyond conventional schemes of the therapy the alternative therapy of CD (acupuncture, yoga, phytoestrogen collections, and food additives) is discussed. For heightening the efficiency and safety of the therapy of CD the training in detection of CD signs both for female patients and nurses, psychologists, social workers is proposed.

show abstract

“…A recent study has directly correlated the difficulty in staying asleep with the presence of VMS in postmenopausal women [26]. Vincent et al has shown that VMS not only directly and negatively influence sleep, and but also may have an indirect effect on mood, partly mediated by sleep difficulty [27]. …”

Section: Vasomotors Symptomsmentioning

confidence: 99%

Contraceptive Method Mix Utilization and its Associated Factors among Married Women in Gedeo Zone, Southern Nations, Nationality and People Region-Ethiopia: A Community based Cross Sectional Study

Jehan

Masters-Isarilov

Salifu

et al. 2015

Epidemiology (Sunnyvale)

View full text Add to dashboard Cite

One of the core symptoms of the menopausal transition is sleep disturbance. Peri-menopausal women often complain of difficulties initiating and/or maintaining sleep with frequent nocturnal and early morning awakenings. Factors that may play a role in this type of insomnia include vasomotor symptoms, changing reproductive hormone levels, circadian rhythm abnormalities, mood disorders, coexistent medical conditions, and lifestyle. Other common sleep problems in this age group, such as obstructive sleep apnea and restless leg syndrome, can also worsen the sleep quality. Exogenous melatonin use reportedly induces drowsiness and sleep and may ameliorate sleep disturbances, including the nocturnal awakenings associated with old age and the menopausal transition. Recently, more potent melatonin analogs (selective melatonin-1 (MT1) and melatonin-2 (MT2) receptor agonists) with prolonged effects and slow-release melatonin preparations have been developed. They were found effective in increasing total sleep time and sleep efficiency as well as in reducing sleep latency in insomnia patients. The purpose of this review is to give an overview on the changes in hormonal status to sleep problems among menopausal and postmenopausal women.

show abstract

Sleep difficulty mediates effects of vasomotor symptoms on mood in younger breast cancer survivors

Abstract: VMS, sleep and mood disturbance are commonly experienced by younger women with breast cancer. Using SEMod, we demonstrate for the first time that VMS may directly influence sleep in these women. VMS may have an indirect effect on mood, partly mediated by sleep difficulty.

Cited by 23 publications

References 30 publications

Associations among menopausal symptoms, sleep and fatigue in Taiwanese women with endometrial cancer

Associations among menopausal symptoms, sleep and fatigue in Taiwanese women with endometrial cancer

Depressive disorders in women of climacteric age (review of foreign literature for 2012–2016)

Contraceptive Method Mix Utilization and its Associated Factors among Married Women in Gedeo Zone, Southern Nations, Nationality and People Region-Ethiopia: A Community based Cross Sectional Study

Contact Info

Product

Resources

About